FDA Inspection
Istituto di Ricerche Biomediche Antoine Marxer RBM S.p.A.Istituto di Ricerche Biomediche Antoine Marxer RBM S.p.A. – FDA Inspection, Jul 4, 2017
Record Details
This FDA Inspection record concerns Istituto di Ricerche Biomediche Antoine Marxer RBM S.p.A., with an inspection on July 4, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- July 4, 2017
- Product Type
- Drugs
View Company Profile
ID · 39e48fa6-b64c-4898-adaf-cbfd4e099e06
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1028388
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Istituto di Ricerche Biomediche Antoine Marxer RBM S.p.A.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| September 30, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 4, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 24, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Istituto di Ricerche Biomediche Antoine Marxer RBM S.p.A.
- FDA Inspection 1169368 - 2021-09-30
- FDA Inspection 895868 - 2014-07-04
- FDA Inspection 733880 - 2011-06-24
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.